Programme

Download invitation (including programme)

Day 1 - Friday 09 March 2018

17:00
Registration, drinks and finger food
Exhibition
17:50
Introduction
Main auditorium
18:00
Renal cancer
Main auditorium
18:00
Can guidelines follow evidence?
Main auditorium
18:30
Case discussion
Main auditorium
19:00
Bladder cancer
Main auditorium
19:00
Immunotherapy in bladder cancer and what about autoimmune adverse events?
Main auditorium
19:30
Case discussion
Main auditorium
20:00
Break
Exhibition
20:30
Prostate cancer
Main auditorium
20:30
Sequencing in prostate cancer – an intriguing discussion
Main auditorium
21:00
Case discussion
Main auditorium
21:30
Take home messages
Main auditorium
21:45
Walking dinner buffet
Exhibition

Day 2 - Saturday 10 March 2018

08:00
Welcome & registration
Registration desk
08:25
Introduction
Main auditorium
08:30
Biomarkers in the era of immunotherapy
Main auditorium
08:30
Keynote lecture
Main auditorium
09:00
Q&A
Main auditorium
09:10
Active surveillance in prostate cancer
Main auditorium
09:10
Keynote lecture
Main auditorium
09:40
Q&A
Main auditorium
09:50
Penile cancer
Main auditorium
09:50
Keynote lecture
Main auditorium
10:20
Q&A
Main auditorium
10:30
Coffee break
Exhibition
11:00
Congress highlights
Main auditorium
11:00
Urologist
Main auditorium
11:10
Radiation oncologist
Main auditorium
11:20
Medical oncologist
Main auditorium
11:30
What do we still need to know about the treatment of RCC?
Main auditorium
11:30
Keynote lecture
Main auditorium
11:50
Q&A
Main auditorium
12:00
Overview of academic trials running in Belgium
Main auditorium
12:00
Adjuvant radiotherapy after radical cystectomy
Main auditorium
12:05
Local treatment of metastatic prostate cancer: interim analysis
Main auditorium
12:10
SAVE trial: salvage RT for prostate cancer with ADT versus AAT
Main auditorium
12:15
Evaluation and predictive value of genetic polymorphisms in the management of hormonal treatment of prostate cancer
Main auditorium
12:20
Avelumab as neoadjuvant therapy in subjects with muscle-invasive urothelial cancer (AURA trial)
Main auditorium
12:25
Q&A
Main auditorium
12:30
What about oligometastatic approach in uro-oncology?
Main auditorium
12:30
Keynote lecture
Main auditorium
12:50
Q&A
Main auditorium
13:00
Adjourn
Main auditorium
13:10
Walking lunch
Exhibition
  • Keynote lecture
  • Clinical case discussions
  • Active debate